Literature DB >> 2174753

Biosynthesis and biological activity of leukotriene B4.

P Borgeat1, P H Naccache.   

Abstract

The leukotrienes are a family of biologically active molecules derived from arachidonic acid. While prostaglandins and thromboxanes are products of the cyclooxygenase pathway of arachidonic acid metabolism, the leukotrienes are formed by arachidonate 5-lipoxygenase, an enzyme present in phagocytes, mast cells, and basophils. Inflammatory stimuli, such as chemotactic peptides, platelet-activating factor, phagocytic particles, and immunological stimuli, which activate phagocytes and mast cells, stimulate leukotriene synthesis. Leukotriene B4, a dihydroxy derivative of arachidonic acid, has a unique stimulatory activity on important functional responses of phagocytes; leukotriene B4 exerts chemotactic and chemokinetic activity towards phagocytes in vitro and in vivo, and it is a putative mediator of inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174753     DOI: 10.1016/0009-9120(90)90272-v

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

1.  Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.

Authors:  T Takano; C B Clish; K Gronert; N Petasis; C N Serhan
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4.

Authors:  J Gosselin; M Savard; M Tardif; L Flamand; P Borgeat
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 3.  Lipid mediators as agonists for the resolution of acute lung inflammation and injury.

Authors:  Caroline Bonnans; Bruce D Levy
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-21       Impact factor: 6.914

Review 4.  Lipoxins: resolutionary road.

Authors:  Paola Maderna; Catherine Godson
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

5.  Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

Authors:  Anna Planagumà; Shamsah Kazani; Gautham Marigowda; Oliver Haworth; Thomas J Mariani; Elliot Israel; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; William J Calhoun; Mario Castro; Kian Fan Chung; Benjamin Gaston; Nizar N Jarjour; William W Busse; Sally E Wenzel; Bruce D Levy
Journal:  Am J Respir Crit Care Med       Date:  2008-06-26       Impact factor: 21.405

6.  LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space.

Authors:  E Pace; M Profita; M Melis; A Bonanno; A Paternò; C H Mody; M Spatafora; M Ferraro; L Siena; A M Vignola; G Bonsignore; M Gjomarkaj
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.

Authors:  D J Fretland; D L Widomski; C P Anglin; T D Penning; S Yu; S W Djuric
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

8.  Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.

Authors:  D J Fretland; C P Anglin; M Bremer; P Isakson; D L Widomski; S K Paulson; S H Docter; S W Djuric; T D Penning; S Yu
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

9.  Leukotriene synthesis in calcium-depleted human neutrophils: arachidonic acid release correlates with calcium influx.

Authors:  E Krump; M Pouliot; P H Naccache; P Borgeat
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

10.  Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.

Authors:  E Krump; G Lemay; P Borgeat
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.